Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.
Journal: Bioorganic & medicinal chemistry letters 20130801
Title: Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.
Journal: Nature genetics 20120801
Title: The receptor tyrosine kinase inhibitor amuvatinib (MP470) sensitizes tumor cells to radio- and chemo-therapies in part by inhibiting homologous recombination.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20111001
Title: MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer.
Journal: BMC cancer 20090101
Title: The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells.
Journal: Radiation oncology (London, England) 20090101
Title: A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors.
Journal: Oncogene 20070607
